High-risk gestational trophoblastic neoplasia at Gujarat cancer and research institute: Thirteen years of experience

Journal of Reproductive Medicine for the Obstetrician and Gynecologist

Volumn 55, Issue 7-8, 2010, Pages 333-340

  Chauhan, Anjana ^a   Dave, Kalpana ^a   Desai, Ava ^a   Mankad, Meeta ^a   Patel, Shilpa ^a   Dave, Pariseema ^a  

^a GUJARAT CANCER AND RESEARCH INSTITUTE   (India)

Author keywords

EMA CO; Gestational trophoblastic tumors; High risk gestational trophoblastic tumors

Indexed keywords

BLEOMYCIN; CISPLATIN; CYCLOPHOSPHAMIDE; DACTINOMYCIN; ETOPOSIDE; METHOTREXATE; VINBLASTINE; VINCRISTINE; ANTINEOPLASTIC AGENT; BEP PROTOCOL; EMA CO PROTOCOL; EMA-CO PROTOCOL; PVB PROTOCOL;

ABDOMINAL PAIN; ADULT; ALOPECIA; ARTICLE; BRAIN METASTASIS; CANCER COMBINATION CHEMOTHERAPY; CANCER GROWTH; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RESISTANCE; CONVULSION; COUGHING; FEMALE; FEVER; HEMATOLOGIC DISEASE; HEMIPLEGIA; HEMOPTYSIS; HUMAN; INCONTINENCE; JAUNDICE; LIVER FUNCTION; LIVER METASTASIS; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; PRIORITY JOURNAL; SENSORY DYSFUNCTION; SIDE EFFECT; STOMATITIS; THORAX PAIN; TREATMENT OUTCOME; TROPHOBLASTIC TUMOR; VAGINA BLEEDING; VOMITING; DRUG RESISTANCE; INDIA; METASTASIS; MORTALITY; PATHOLOGY; PREGNANCY; REMISSION; RETROSPECTIVE STUDY; UTERUS CANCER;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLEOMYCIN; CISPLATIN; CYCLOPHOSPHAMIDE; DACTINOMYCIN; DRUG RESISTANCE, NEOPLASM; ETOPOSIDE; FEMALE; GESTATIONAL TROPHOBLASTIC NEOPLASMS; HUMANS; INDIA; METHOTREXATE; NEOPLASM METASTASIS; PREGNANCY; REMISSION INDUCTION; RETROSPECTIVE STUDIES; UTERINE NEOPLASMS; VINBLASTINE; VINCRISTINE;

EID: 77957288983     PISSN: 00247758     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Berkowitz RS, Goldstein DP: Gestational trophoblastic neoplasia. In Practical Gynecologic Oncology. Third edition. Edited by JS Berek, NF Hacker. Baltimore, Williams & Wilkins, 1989, pp 441-468
2. Soper JT: Gestation trophoblastic disease. Clin Obstet Gynecol 2003;46:511-611
3. Newlands ES, Bagshawe KD, Begent RH, et al: Results with the EMA/CO (etoposide, methotrexate, actinomycin D, cyclophosphamide, vincristine) regimen in high risk gestational trophoblastic tumors, 1979 to 1989. BJOG 1991;98:550-557
4. Newlands ES, Bagshawe KD, Begent RH, et al: Developments in chemotherapy for medium- and high-risk patients with gestational trophoblastic tumors (1979-1984). BJOG 1986;93:63-69
5. Bower M, Newlands ES, Holden L, et al: EMA/CO for highrisk gestational trophoblastic tumors: Results from a cohort of 272 patients. J Clin Oncol 1997;15:2636-2643
6. Schlaerth JB: Tumors of the placental trophoblast. In Synopsis of Gynecologic Oncology. Fourth edition. Edited by CP Morrow, JP Curtin, DE Townsend DE. New York, Churchill Livingstone Inc., 1993, pp 311-350
7. Kohorn EI: The new FIGO 2000 staging and risk factor scoring system for gestational trophoblastic disease: Description and critical assessment. Int J Gynecol Cancer 2001;11:73-77
8. Matsui H, Iitsuka Y, Suzuka K, et al: Combination chemotherapy with methotrexate, etoposide, and actinomycin D for high-risk gestational trophoblastic tumors. Gynecol Oncol 2000;78:28-31
9. Jones WB, Cardinale C, Lewis JL Jr: Management of highrisk gestational trophoblastic disease: The Memorial Hospital experience. Int J Gynecol Cancer 1997;7:27-33
10. Kim SJ, Bae SN, Kim H, et al: Risk factors for the prediction of treatment failure in gestational trophoblastic tumors treated with EMA/CO regimen. Gynecol Oncol 1998;71:247-253
11. Bafna UD, Ahuja VK, Umadevi K, et al: Gestational trophoblastic tumors: Situation analysis in a third world regional cancer center. Int J Gynecol Cancer 1997;7:197-204
12. El-Lamine IKL, El Sayed HM, Badawie AG, et al: Evolution of treatment of high-risk metastatic gestational trophoblastic tumors: Ain Shams University experience. Int J Gynecol Cancer 2006;16:866-874
13. Matsui H, Iitsuka Y, Suzuka K, et al: Risk of abnormal pregnancy completing chemotherapy for gestational trophoblastic tumor. Gynecol Oncol 2003;88:104-107
14. Kim JH, Park DC, Bae SN, et al: Subsequent reproductive experience after treatment for gestational trophoblastic disease. Gynecol Oncol 1998;71:108-112
15. Woolas RP, Bower M, Newlands ES, et al: Influence of chemotherapy for gestational trophoblastic disease on subsequent pregnancy outcome. BJOG 1998;105:1032-1035
16. Newlands ES, Bower M, Holden L, et al: The management of high-risk gestational trophoblastic tumours (GTT). Int J Gynecol Obstet 1998;6:S65-S70
17. Lurain JR, Singh DK, Schink JC: Primary treatment of metastatic high-risk gestational trophoblastic neoplasia with EMA-CO chemotherapy. J Reprod Med 2006; 51:767-772